Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Pittsburg, CA – FDA Inspections
Inspection records and compliance data for Linde Inc. in Pittsburg, California. 3 FDA inspections on record, last inspected September 01, 2026. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Pittsburg, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected July 1, 2010. Last inspected September 1, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 1, 2026 | NAI | Human Drugs · Drug Quality Assurance | 1336914 |
| July 9, 2015 | NAI | Human Drugs · Drug Quality Assurance | 935053 |
| July 1, 2010 | NAI | Human Drugs · Drug Quality Assurance | 670007 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$522.49
Market cap
$239.9B
Price as of
November 13, 2026
FEI Number
2910874
Address
2000 Loveridge Rd, Pittsburg, California 94565, United States
Country
United States
ID: 273be37c-b79c-43f0-aa56-214a104a7bbb